21647 ⎘
Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups -
MicroRNA-198 as a tumor suppressor in ovarian cancer
#902Pharmaceutical compositions and their use for treatment of cancer and autoimmune diseases
#903Tank-binding kinase-1 PROTACs and associated methods of use
#904Methods of reducing the risk of a cardiovascular event in a subject at risk for cardiovascular disease
#905Sphingosine pathway modulating compounds for the treatment of cancers
#906Biologically relevant orthogonal cytokine/receptor pairs
#907Effervescent formulation based on pyridoxal-5-phosphate
#908Combined pharmaceutical composition
#909Compositions and methods of use of phorbolesters
#910METHODS AND COMPOSITIONS USING IMMUNOMODULATORY COMPOUNDS FOR TREATMENT AND MANAGEMENT OF CANCERS AND OTHER DISEASES
#911Topical antimicrobial composition
#912Methods for cardiomyocyte survival, proliferation or differentiation by NRG-2
#913COMBINATION THERAPY FOR EFFECTING WEIGHT LOSS AND TREATING OBESITY
#914BLENDED FORMULATIONS
#915Anti-amyloid beta antibodies binding to a cyclic amyloid beta peptide
#916Composition for treatment of neurodegenerative disease
#917Triple combination therapy for treating Crohn's disease
#918Pharmaceutical composition containing celecoxib
#919Prevention of adverse effects caused by CD3 specific binding domains
#920Use of substituted hexitols including dianhydrogalactitol and analogs to treat neoplastic disease and cancer stem cells including glioblastoma multiforme and medulloblastoma
#921USE OF RASAGILINE FOR THE TREATMENT OF RESTLESS LEGS SYNDROME
#922Insulin resistance and beta cell function using lysine-based supplements
#923Formulations of milciclib and therapeutic combinations of the same for use in the treatment of cancer
#924Therapeutic Composition for Coincident Drinking Detoxification
#925Recovery and processing of human embryos formed in vivo
#926Altering microbial populations and modifying microbiota
#927Compositions and methods for treating and preventing infections
#928Compositions and methods for treatment of homocystinuria
#929Herbo-mineral formulation for prevention, treatment and management of diabetes and method of preparation thereof
#930Compositions and methods for inhibiting kinases
#931COMBINATION OF LAQUINIMOD AND PRIDOPIDINE FOR TREATING NEURODEGENERATIVE DISORDERS, IN PARTICULAR HUNTINGTON'S DISEASE
#932Crystalline form of lumacaftor
#933STATIN + VITAMIN D COMBINATION DRUG AND METHOD OF USE
#934USE OF GABOXADOL IN THE TREATMENT OF TINNITUS
#935Inhalant formulation containing sulfoalkyl ether cyclodextrin and corticosteroid
#936ExPEC glycoconjugate vaccine formulations
#937Method of using a gel, rinse, and spray for management of post-oral surgical recovery and maintenance of oral health
#938Topical medicament for skin and mucosal injuries
#939Systems and methods for thrombosis prevention
#940Topical Skin Care Compositions and Methods
#941Methods for inhibiting muscle atrophy
#942Methods for treating subjects with Prader-Willi syndrome or Smith-Magenis syndrome
#943COMPOSITIONS AND METHODS FOR TREATMENT RELATED TO FALL AND FALL FREQUENCY IN NEURODEGENERATIVE DISEASES
#944Psilocybin compositions
#945Amino acid compositions and methods for the treatment of liver diseases
#946Methods and means for efficient skipping of at least one of the following exons of the human Duchenne muscular dystrophy gene: 43, 46, 50-53
#947INHIBITORS OF CYCLIN-DEPENDENT KINASE 7 (CDK7)
#948CANNABINOIDS IN COMBINATION WITH NON-CANNABINOID CHEMOTHERAPEUTIC AGENTS
#949Methods and compositions for preserving retinal ganglion cells
#950Method for olfactory improvement with saccharide
#951NERIDRONIC ACID FOR TREATING COMPLEX REGIONAL PAIN SYNDROME
#952CENICRIVIROC FOR THE TREATMENT OF FIBROSIS
#953Pharmaceutical composition comprising eicosapentaenoic acid and derivatives thereof and a statin
#954Systems pharmacology for treating ocular disorders
#955Procaspase combination therapy for glioblastoma
#956Procaspase 3 activation by combination therapy
#957Use of tetrahydrocannabinol and/or cannabidiol for increasing radiosensitivity in the treatment of a brain tumour
#958Glucagon Antagonists
#959COMPOSITIONS AND METHODS FOR TREATING OPIOID RECEPTOR ASSOCIATED DISEASES
#960Buffered microencapsulated compositions and methods
#961Buffered microencapsulated compositions and methods
#962Disease-associated antigens and methods of use thereof
#963Compositions and methods to promote bone formation and their uses including for the treatment of cancer
#964Substituted 3,4,5,6,8,10,14,14a-octahydro-2h-2,6-methanopyrido[1′,2′:4,5]pyrazino[2,1-b][1,3]oxazocines and methods for treating viral infections
#965FUMAGILLOL SPIROCYCLIC COMPOUNDS AND FUSED BICYCLIC COMPOUNDS AND METHODS OF MAKING AND USING SAME
#966Compounds for treatment of cancer
#9675-(N-BENZYL TETRAHYDROISOQUINOLIN-6-YL) PYRIDIN-3-YL ACETIC ACID DERIVATIVES AS INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS REPLICATION
#968Pharmaceutical compositions of roflumilast in aqueous blends of water-miscible, pharmaceutically acceptable solvents
#969Use of hyaluronidase for the prevention or treatment of arterial hypertension or cardiac insufficiency
#970HSP for use in treatment for imiquimod related side effects
#971Combination therapy for ischemia
#972ANTI-CANCER DRUG COMPOSITION INCLUDING GANODERMA EXTRACT AND AMPHOTERICIN B
#973Selective Chemotherapy Treatments and Diagnostic Methods Related Thereto
#974Method of increasing relative abundance of oscillospira
#975FIXED DOSE COMBINATION FOR PAIN RELIEF WITHOUT EDEMA
#976METHOD OF TREATING MICROBIAL INFECTIONS
#977Methods and compositions for treating viral or virally-induced conditions
#978METHODS FOR INHIBITING TIE-2 KINASE USEFUL IN THE TREATMENT OF CANCER
#979METHODS AND COMPOSITIONS FOR TREATMENT OF EPILEPTIC DISORDERS
#980CONTROLLED RELEASE PHARMACEUTICAL COMPOSITIONS COMPRISING A FUMARIC ACID ESTER
#981CONTROLLED RELEASE PHARMACEUTICAL COMPOSITIONS COMPRISING A FUMARIC ACID ESTER
#982CONTROLLED RELEASE PHARMACEUTICAL COMPOSITIONS COMPRISING A FUMARIC ACID ESTER
#983COMBINATION THERAPY FOR TREATMENT OF MULTIPLE SCLEROSIS
#984Therapy for transthyretin-associated amyloidosis
#985METHOD OF REDUCTION MEDICATION IN TREATING DRAVET SYNDROME
#986METHOD OF REDUCING SEIZURE TYPE EXPERIENCED BY A DRAVET PATIENT
#987METHOD OF INCREASING TIME BETWEEN CONVULSIVE SEIZURES
#988Milrinone controlled-release formulation
#989COMBINATION TABLET WITH CHEWABLE OUTER LAYER
#990FUSION PROTEINS FOR TREATING A METABOLIC SYNDROME
#9916-ETHER/THIOETHER-PURINES AS TOPOISOMERASE II CATALYTIC INHIBITORS AND THEIR USE IN THERAPY
#992Calcium channel agonists
#993NEW CLASS OF MU-OPIOID RECEPTOR AGONISTS
#994Compounds and methods of treating infections
#995ANTIOXIDANT DIETARY SUPPLEMENT AND RELATED METHOD
#996PROBIOTIC COMPOSITIONS AND METHODS FOR THE TREATMENT OF OBESITY AND OBESITY-RELATED CONDITIONS
#997NITRITE FORMULATIONS AND THEIR USE AS NITRIC OXIDE PRODRUGS
#998Methods and compositions for the activation of gamma-delta T-cells
#999Combination of PI3K Inhibitor and C-Met Inhibitor
#1000Therapeutic Compositions
#1001Bromodomain and extra-terminal protein inhibitor combination therapy
#1002COMBINATION MEDICATION
#1003Cyclooxygenase Inhibitor and Calcium Channel Antagonist Compositions and Methods for Use in Urological Procedures
#1004Pharmaceutical compositions containing a PDE4 inhibitor and a PI3 delta or dual PI3 delta-gamma kinase inhibitor
#1005Synergistic effect of anti-trop-2 antibody-drug conjugate in combination therapy for triple-negative breast cancer when used with microtubule inhibitors or PARP inhibitors
#1006Derivatives of korormicin useful as antibiotics
#1007METHODS OF REDUCING THE RISK OF A CARDIOVASCULAR EVENT IN A SUBJECT ON STATIN THERAPY
#1008Methods and compositions to inhibit dependence on opioids
#1009Methods and Compositions to Inhibit Symptoms Associated with Opioid Withdrawal
#1010Formulation for inhibiting formation of 5-HTagonists and methods of using same
#1011METHOD OF TREATING CANCER USING SELECTIVE ESTROGEN RECEPTOR MODULATORS
#1012Pharmaceutical compositions of pimobendan
#1013Pharmaceutical compositions of pimobendan
#1014ANTI-EMP2 THERAPY REDUCES CANCER STEM CELLS
#1015Inhibitors of KRAS G12C and methods of using the same
#1016Derivatives and methods of treating hepatitis B infections
#1017Mixtures of cannabinoid compounds, and production and use thereof
#1018Small molecule androgen receptor inhibitors and methods of use thereof
#1019Sulfamoyl-arylamides and the use thereof as medicaments for the treatment of hepatitis B
#1020SUBSTRATES FOR NITRIC OXIDE RELEASING DEVICES
#1021Methods and kits for use in preventing and treating vulvovaginal candidiasis
#1022Synergistic combinations of caffeine, ginkgo biloba and beta-phenylethylamine
#1023AUTOLOGOUS AND ALLOGENIC MACROPHAGES AND MONOCYTES FOR USE IN THERAPEUTIC METHODS
#1024Topical wash composition for use in acne patients
#1025Therapeutic uses of pharmaceutical compositions comprising cyclic boronic acid ester derivatives
#1026Methods for Suppressing Allergic Reactions
#1027COMPOSITIONS AND METHODS FOR TREATING OR PREVENTING ATRIAL FIBRILLATION
#1028USE OF GABOXADOL IN THE TREATMENT OF NARCOLEPSY
#1029Extended release methazolamide formulation
#1030Methods of reducing the risk of a cardiovascular event in a subject on statin therapy
#1031Methods of reducing the risk of a cardiovascular event in a subject on statin therapy
#1032Ophthalmic drug delivery
#1033INHIBITORS OF DEK PROTEIN AND RELATED METHODS
#1034Organomedicinals for imaging and treatment of neurodegenerative disorders
#1035Interleukin 15 protein complex
#1036INTERLEUKIN-18 VARIANTS AND METHODS OF USE
#1037MATERIALS AND METHODS FOR MODULATING GLUCOSE UPTAKE
#1038Systems and methods for improved delivery of osteoinductive molecules in bone repair
#1039Combination product for the prevention of sexually transmitted infections
#1040METHOD FOR FOODBORNE PATHOGEN REDUCTION IN POULTRY
#1041Radiation - Sterilized Biodegradable Drug Delivery Compositions
#1042Compounds for use in wound healing and angiogenesis
#1043FIXED DOSE COMBINATION FOR PAIN RELIEF WITHOUT EDEMA
#1044Compound for inhibition of delta-5-desaturase (D5D) and treatment of cancer and inflammation
#1045METHODS FOR TREATING OR PREVENTING CARDIOVASCULAR DISORDERS AND LOWERING RISK OF CARDIOVASCULAR EVENTS
#1046Method of increasing bioavailability and/or prolonging ophthalmic action of a drug
#1047Combinations for the treatment of neuroblastoma
#1048Solid forms of N-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide
#1049NOVEL PHARMACEUTICAL USES
#1050Treatment of debilitating fatigue
#1051Method for treating hepatic encephalopathy
#1052Treatment of circadian rhythm disorders
#1053Treatment of diseases associated with hepatic stellate cell activation using ammonia-lowering therapies
#1054Pharmaceutical composition for improving or preventing progression of chronic kidney disease
#1055Method for supporting memory function and/or cognitive function
#1056Controlled release dosage form with enhanced pharmacokinetics
#1057Compositions and methods for delivery of omeprazole plus acetylsalicylic acid
#1058Artificial saliva
#1059Compositions and methods for treating cancers
#1060MicroRNA composition for the treatment of neuroblastoma
#1061Methods and compositions relating to anti-CHI3L1 antibody reagents to treat cancer
#1062FULLY HUMAN ANTIBODIES AGAINST HUMAN 4-1BB
#1063HEPATOPROTECTANT ACETAMINOPHEN MUTUAL PRODRUGS
#1064Compositions and Methods for the Treatment of Fatty Acid Metabolism Disorders
#1065COMPOUNDS FOR THE TREATMENT OF OBESITY AND METHODS OF USE THEREOF
#1066Polymeric conjugates and uses thereof
#1067Silicone-based composition for skin treatment
#1068Compound to treat Sjogren's syndrome
#1069Insulin Glargine/Lixisenatide Fixed Ratio Formulation
#1070Pharmaceutical composition comprising IL-34 and a mTOR inhibitor
#1071TREATING NEURODEGENERATIVE DISEASES WITH PROGRANULIN
#1072Compositions and methods for controlling carbohydrate and fat metabolism
#1073RAR selective agonists in combination with immune modulators for cancer immunotherapy
#1074COMPOSITION AND METHOD FOR TREATING MIGRAINES
#1075Methods of treating a bacterial infection using a fixed-dose pharmaceutical composition comprising three antibiotics
#1076COMPOSITIONS COMPRISING BETA-GLUCOGALLIN AND THERAPEUTIC APPLICATIONS THEREOF IN CONTROLLED KINETICS OF CARBOHYDRATE BREAKDOWN AND MONOSACCHARIDE ABSORPTION
#1077Oral lipid supplements for treating pain and fibromyalgia
#1078Concentrated therapeutic phospholipid compositions
#1079Methods and compositions for treating psoriasis
#1080Methods and Compositions for Treating Thyroid-Related Medical Conditions with Reduced Folates
#1081Compositions and methods for treating cancer
#1082PHARMACEUTICAL COMPOSITION COMPRISING AN OMEGA-3 FATTY ACID AND A HYDROXY-DERIVATIVE OF A STATIN AND METHODS OF USING SAME
#1083ENHANCEMENT OF IMPAIRED MOTOR AND MENTAL FUNCTIONS, USING DEXTROMETHORPHAN AND OXIDASE ENZYME INHIBITOR
#1084Heteroaryl-ketone fused azadecalin glucocorticoid receptor modulators
#1085Self-Emulsifying Compositions of CB2 Receptor Modulators
#1086NEW DRUG FOR THE TREATMENT AND/OR PREVENTION OF DEPRESSIVE DISORDERS
#1087AZETIDINE DERIVATIVE, PREPARATION METHOD THEREFOR, AND USE THEREOF
#1088Chemotherapeutic Methods
#1089Administration of hypoxia activated prodrugs and antiangiogenic agents for the treatment of cancer
#1090Crosslinker enhanced repair of connective tissues
#1091Compositions containing benzoate compound and tannic acid for treating central nervous system disorders
#1092Enhanced expression of RNA vectors
#1093Formulation of Curcumin with Enhanced Bioavailability of Curcumin and method of preparation and treatment thereof
#1094Cannabinoid compositions comprising cannabis oil and methods of making thereof
#1095Topical sanitizing formulations and uses thereof
#1096ASSAYS FOR B-TYPE NATRIURETIC PEPTIDE ANALOGUES RESISTANT TO PROLYL-SPECIFIC DIPEPTIDYL DEGRADATION
#1097Compositions and Methods For Treating Cachexia
#1098Compositions and methods for inhibiting kinases
#1099PREVENTION OF HYPOGLYCEMIA IN DIABETES MELLITUS TYPE 2 PATIENTS
#1100METHODS FOR TREATING MUSCULAR DYSTROPHY
#1101Compositions and methods for treating an infection
#1102Proton-motive force stimulation to potentiate aminoglycoside antibiotics against persistent bacteria
#1103COMPOSITION AND METHOD FOR TREATMENT OF DEPRESSION AND PSYCHOSIS IN HUMANS
#1104METHOD OF MODULATING RIBONUCLEOTIDE REDUCTASE
#1105ENHANCEMENT OF IMPAIRED MOTOR AND MENTAL FUNCTIONS, USING DEXTROMETHORPHAN AND OXIDASE ENZYME INHIBITOR
#1106Small molecule inhibitors of pendrin ion exchange and pharmaceutical compositions
#1107Compositions and methods for treating an infection
#1108COMPOSITIONS AND METHODS FOR TREATMENT OF INFLUENZA VIRUS
#1109DOPA Formulations for Treatments of Parkinson's Disease
#1110NITRIC OXIDE GENERATING FORMULATIONS AND KITS
#1111METHOD FOR PRODUCING CELLULOSE FIBERS SUITABLE FOR USE IN A THICKENING COMPOSITION, METHOD FOR PRODUCING A THICKENING COMPOSITION, AND METHOD FOR THICKENING A COMPOSITION
#1112Anti-CTLA-4 antibodies and uses thereof
#1113Treatment for multiple myeloma (MM)
#1114USE OF IL-1beta BINDING ANTIBODIES
#1115ALT-803 IN COMBINATION WITH ANTI-CD38 ANTIBODY FOR CANCER THERAPIES
#1116Substituted urea depsipeptide analogs as activators of the CLPP endopeptidase
#1117Artificial catalyst system for selective acylation of chromosome protein
#1118Carboxylic diarylthiazepineamines as mu-opioid receptor agonists
#1119Nuclear receptor modulators and their use for the treatment and prevention of cancer
#1120Cadherin-17 specific antibodies and cytotoxic cells for cancer treatment
#1121Pharmaceutical composition for the parenteral administration of ultrashort-effective beta-adrenoreceptor antagonists
#1122IMPAIRED ENERGY PROCESSING DISORDERS AND MITOCHONDRIAL DEFICIENCY
#1123METHODS OF USING SMECTITE COMPOSITIONS FOR TREATING CLOSTRIDIUM DIFFICILE ASSOCIATED DISEASES AND SYMPTOMS
#1124Compositions for treating candidiasis infections
#1125COMPOSITIONS AND METHODS FOR TREATING INFLAMMATORY ARTHRITIS
#1126NANOBUBBLE-CONTAINING COMPOSITION AND USE THEREOF
#1127Gel formulation for the prevention and treatment of gastrointestinal distress in horses and other species
#1128COMPOSITION AND METHODS OF INHIBITING AMYLASE-MEDIATED HYDROLYSIS OF ALPHA (1 to 4)-LINKED GLUCOSE POLYMERS
#1129Methods and Pharmaceutical Compositions for the Prophylactic Treatment of Peritoneal Carcinomatosis
#1130COMPOSITIONS AND METHODS FOR THE TREATMENT OF HCV INFECTION
#1131Natural combination hormone replacement formulations and therapies
#1132Combination therapy for the treatment of cancer
#1133Methods and compositions for treating abnormal cell growth
#1134Methods and compositions for treatment of mitochondrial toxicity
#1135MATERIALS AND METHODS FOR IMPROVING GASTROINTESTINAL FUNCTION
#1136Taxane analogs for the treatment of brain cancer
#1137Reducing the risk of pathological effects of traumatic brain injury
#1138TREATMENT AND PREVENTION OF BONE LOSS USING RESOLVINS
#1139METHODS FOR TREATING NEUROBLASTOMA
#1140TRANSDERMAL FORMULATIONS FOR DELIVERY OF PROPIONIC AND ACETIC ACID NSAIDS, AND THEIR USE IN THE TREATMENT OF NSAID-RESPONSIVE DISEASES AND CONDITIONS
#1141Composition for treating diabetes, containing extract of yukmijihwangtang
#1142Igmesine for use in the treatment of neurodegenerative diseases
#1143COMPOSITIONS AND METHODS FOR INHIBITING BIOFILM-FORMING BACTERIA
#1144Combination therapy for COPD
#1145ANTIMICROBIAL COMPOSITION
#1146METHODS OF DIAGNOSING AND TREATING B CELL ACUTE LYMPHOBLASTIC LEUKEMIA
#1147Method for separating cells using immunorosettes and magnetic particles
#1148Compositions and methods of treatment with prodrugs of tizoxanide, an analogue or salt thereof
#1149AMINOBENZIMIDAZOLE DERIVATIVES
#1150ANTIMICROBIAL LOCKING SOLUTIONS COMPRISING TAURINAMIDE DERIVATIVES AND BIOLOGICALLY ACCEPTABLE SALTS AND ACIDS, WITH THE ADDITION OF SMALL CONCENTRATIONS OF HEPARIN
#1151Assessment of coronary heart disease with carbon dioxide
#1152ST-246 liquid formulations and methods
#1153Cancer treatment
#1154Combination preparation including a corticosteroid and exosomes
#1155Compositions comprising kakadu plum extract or acai berry extract
#1156Herbal compositions and methods for the prevention and treatment of plant of nail infections
#1157Cosmetic compositions
#1158Nutritional composition
#1159Anti-angiogenic therapy based on exosomes derived from menstrual stem cells
#1160Rapid release pharmaceutical formulations containing algal cellulose
#1161Anthranilyl-adenosinemonosulfamate analogs and uses thereof
#1162Chemicals and methods to prevent and treat TGF-beta mediated activation of fibroblasts to reduce and treat cancer and fibrosis
#1163COMPOSITIONS AND METHODS FOR THE TREATMENT OF ATHEROSCLEROSIS AND HEPATOSTEATOSIS AND OTHER DISEASES
#1164COMBINATION THERAPY FOR CASTRATION-RESISTANT PROSTRATE CANCER
#1165COMPOSITION, FORMULATIONS AND METHODS OF MAKING AND USING BOTANICALS AND NATURAL COMPOUNDS FOR THE PROMOTION OF HEALTHY BRAIN AGING
#1166Product and method for treating diarrhea
#1167Anti-neutrophil activity on innate immune response
#1168PHARMACEUTICAL COMPOSITIONS AND ADMINISTRATIONS THEREOF
#1169COMBINATION THERAPY
#1170Cancer therapy
#1171MEDICAMENTS FOR THE TREATMENT OR PREVENTION OF FIBROTIC DEISEASES
#1172TREATMENT OF AUTOIMMUNE DISEASE IN A PATIENT RECEIVING ADDITIONALLY A BETA-BLOCKER
#1173PHARMACEUTICAL COMPOSITION INCLUDING DORZOLAMIDE AND BRIMONIDINE
#1174NOVEL CLASS OF COMPOUNDS FOR THE TREATMENT OF CARDIOVASCULAR DISEASE
#1175Methods and compositions for increasing the anaerobic working capacity in tissues
#1176Phenylketone carboxylate compounds and pharmaceutical compositions for the prevention and treatment of osteoporosis
#1177Snacking product with capsaicin or analogue thereof
#1178ION CHANNEL ACTIVATORS AND METHODS OF USE
#1179SUBLINGUAL AND BUCCAL FILM COMPOSITIONS
#1180Compositions for respiratory delivery of active agents and associated methods and systems
#1181Supplement for the prevention and treatment of gastrointestinal distress in horses and other species
#1182METHODS FOR TREATING HYPERLIPIDEMIA IN DIABETIC PATIENTS BY ADMINISTERING A PCSK9 INHIBITOR
#1183POSTERIOR OCULAR FIBROSIS INHIBITION BY ANTAGONIZING PLACENTAL GROWTH FACTOR
#1184Compositions and methods for inhibiting Wnt signaling
#1185Compositions and methods for treating cancers
#1186Ammonium derivatives, a process for their preparation and pharmaceutical compositions containing them
#1187Processes for producing diazabicyclooctane compounds
#1188Derivatives and methods of treating hepatitis B infections
#1189GLS1 inhibitors for treating disease
#1190Trace elements
#1191Bacterial ghosts for the treatment of cancer
#1192DIPEPTIDYL ALDEHYDES FOR THE TREATMENT AND/OR PREVENTION OF PARASITIC DISEASES
#1193Water extracts of cinnamon and radix astragali
#1194HYDROGENATION OF CANNABIS OIL
#1195Printable cannabinoid and terpene compositions
#1196ENHANCEMENT OF STEM CELL ENGRAFTMENT WITH ONCOSTATIN M
#1197Method of Ex Vivo Enhancement of Immune Cell Activity for Cancer Immunotherapy with a Small Molecule Ablative Compound
#1198ANTITHROMBIN-HEPARIN COMPOSITIONS AND METHODS
#1199Cannabinoid composition and method for treating pain
#1200TOPICAL ANTIFUNGAL PASTES AND METHODS OF USE THEREOF